Order Article Reprints

Greco A, Safi D, Swami U, Ginader T, Milhem M, Zakharia Y. Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review. Cancers. 2019; 11(12):1950. https://doi.org/10.3390/cancers11121950

Greco, Austin, Danish Safi, Umang Swami, Tim Ginader, Mohammed Milhem, and Yousef Zakharia. 2019. "Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review" Cancers 11, no. 12: 1950. https://doi.org/10.3390/cancers11121950

Greco, A., Safi, D., Swami, U., Ginader, T., Milhem, M., & Zakharia, Y. (2019). Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review. Cancers, 11(12), 1950. https://doi.org/10.3390/cancers11121950